Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02246374 · ClinicalTrials.gov registry record · NA
ExAblate Transcranial MRgFUS of the Subthalamic Nucleus for Treatment of Parkinson's Disease
A NA study of Parkinson's Disease, sponsored by InSightec.
- Active
- Registry status
- NA
- Development phase
- 7
- Enrollment target
- 1
- Study location
NCT02246374: Active NA study of Parkinson's Disease, sponsored by InSightec.
NCT02246374 is a NA study of Parkinson's Disease that is active but no longer recruiting, run by InSightec. The registered enrollment target is 7 participants, below the 635-participant average among 158 other Parkinson's Disease trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02246374, a NA study of Parkinson's Disease, is active but no longer recruiting, sponsored by InSightec.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
- 1
- Study location
Study Summary
This is primarily a safety protocol to evaluate the safety of subthalamotomy using Transcranial ExAblate for treatment of Parkinson's Disease (PD) motor features.
Primary Outcome
Safety will evaluate the incidence and severity of adverse events associated with ExAblate subthalamotomy for the treatment of Parkinson's Disease motor features.
Conditions Studied
Interventions
- DEVICE ExAblate Transcranial System
Study Locations (1)
Virginia
- University of Virginia - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2014-09 |
| Est. Completion | 2026-12 |
| Phase | NA |
What the registry record for NCT02246374 still lists
NCT02246374 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 635-participant average among 158 other Parkinson's Disease trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Parkinson's Disease appearing as the primary indexed condition, and to 1 intervention - of which ExAblate Transcranial System is the first listed.
NCT02246374 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT02246374 about?
NCT02246374 is a clinical study titled "ExAblate Transcranial MRgFUS of the Subthalamic Nucleus for Treatment of Parkinson's Disease". This is primarily a safety protocol to evaluate the safety of subthalamotomy using Transcranial ExAblate for treatment of Parkinson's Disease (PD) motor features.
What is the current status of trial NCT02246374?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 7 participants. The study started on 2014-09. Estimated completion is 2026-12.
What conditions does trial NCT02246374 study?
This clinical trial studies the following conditions: Parkinson's Disease.
What interventions are being tested in trial NCT02246374?
The interventions under investigation include: ExAblate Transcranial System (DEVICE).
Who is sponsoring clinical trial NCT02246374?
This trial is sponsored by InSightec, which has 38 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02246374 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Parkinson's Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02246374's enrollment target sits among peer trials
7 153rd of 158 higher than 3 of 158 other Parkinson's Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Parkinson's Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Novel DBS Stimulation Patterns for Treatment of Parkinson's Disease
RECRUITING · NA
-
Feasibility and Safety of a Portable Exoskeleton to Improve Mobility in Parkinson's Disease
RECRUITING · NA
-
Effects of Pallidal Deep Brain Stimulation Location on Motor Impairment in Parkinson's Disease
RECRUITING · NA
-
Remote Dynamic Cycling for the Customized Off-site Rehab in Parkinson's Disease
RECRUITING · NA
-
Deep Brain Stimulation Therapy in Movement Disorders
RECRUITING · NA
-
Combined STN and NBM Deep Brain Stimulation for Mild Cognitive Impairment in Parkinson's Disease
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia